Table 2.
Characteristics of patients with malignant disease and positive antinuclear antibodies according to indirect immunofluorescence pattern.
| Nucleolar(n = 25) | Homogeneous and Speckled (n = 34) | p value | |
|---|---|---|---|
| Mean age at IIF analysis [years (95% CI)] | 61.6 (55.3–67.9) | 68.5 (64–73) | p = 0.09 |
| Mean age at cancer diagnosis [years (95% CI)] | 60 (53.7–66.3) | 66.7 (61.9–71.4) | p = 0.07 |
| Mean age at death [years (95% CI)] | 66.9 (57.6–75.3) | 75 (68.5–81.4) | p = 0.02 |
| Mean delay between cancer diagnosis to death [years (95% CI)] | 3.2 (1.7–4.7) | 4.5 (1.5–7.5) | p = 0.65 |
| AID [n] | 4 (16%) | 10 (29.4%) | p = 0.2 |
| - RA | 2 | 0 | |
| - Granomatosis with polyangeiitis | 1 | 0 | |
| - SLE | 0 | 2 | |
| - SjS | 0 | 1 | |
| - Coeliac disease | 0 | 1 | |
| - DM paraneoplastic | 0 | 1 | |
| - PM paraneoplastic | 1 | 1 | |
| - SSc | 0 | 1 | |
| - Polymyalgia Rheumatica | 0 | 1 | |
| - Horton's Disease | 0 | 1 | |
| - Ulcerative colitis | 0 | 1 |
AID, Autoimmune disease; RA, Rheumatoid arthritis; SLE, Systemic lupus erythematosus; SjS, Sjögren syndrome; DM, Dermatomyositis; PM, Polymyositis; SSc, Systemic sclerosis.